Lv3
330 积分 2024-01-11 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2天前
已完结
Small Cell Lung Cancer: A Review
29天前
已完结
Small cell lung cancer
29天前
已完结
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti–PD-(L)1 Plus Platinum Chemotherapy
1个月前
已完结
Devices for aortoiliac occlusive disease
2个月前
已完结
12P: Camrelizumab plus chemotherapy (Cam-chemo) as first-line (1L) therapy for advanced squamous non-small cell lung cancer (sqNSCLC): 5y update from the phase III CameL-sq trial
2个月前
已关闭
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
3个月前
已完结
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
4个月前
已完结
Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
4个月前
已完结
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
4个月前
已完结
皖公网安备34019202002308
